科学图书馆
-
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCIGibson CM, Mehran R, Bode C et al. -
6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical TrialHong SJ, Shin DH, IVUS-XPL Investigators.
-
Safety of six-month dual antiplatelet therapy after second-generation drug-eluting stent implantation: OPTIMA-C Randomised Clinical Trial and OCT SubstudyLee BK, Kim JS, Lee OH et al.
-
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stentsMauri L, Kereiakes DJ, DAPT Study Investigators.
-
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCIDMF Claassens, GJA Vos, TO Bergmeijer et al.
-
DAPT, Our Genome and ClopidogrelPeter C. Block, M.D., FACC
-
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trialHelft G, Steg PG, OPTImal DUAL Antiplatelet Therapy Trial Investigators.
-
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 TrialHan Y, Xu B, Xu K et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
